ProtoKinetix, Inc.
PKTXDrugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Artemether Sublingual Spray | Phase 3 | Plasmodium Falciparum Malaria | - | - |
Quinine | Phase 2 | Falciparum Malaria | - | - |
Frequently asked questions
What is in ProtoKinetix, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in ProtoKinetix, Inc.'s (PKTX) pipeline across Phase 3, Phase 2. Its lead program is Artemether Sublingual Spray (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is ProtoKinetix, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for ProtoKinetix, Inc. (PKTX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track PKTX biotech catalysts?→
Add PKTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ProtoKinetix, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.